PULSE BIOSCIENCES, INC. — Director's Dealing 2019

Nov 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2019-11-18

Reporting Person: GARDINER SANDRA A. (CFO & EVP Admin. and Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-18	Stock Option (right to buy)	$13.94	A	103842	Acquired	2029-11-18	Common Stock (103842)	Direct
2019-11-18	Stock Option (right to buy)	$13.94	A	103842	Acquired	2029-11-18	Common Stock (103842)	Direct

Footnotes

F1: The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of the grant date, subject to the Reporting Person's continued service through each vesting date.

F2: The shares subject to the option shall vest based upon the achievement of performance objectives, with vesting targets set no less than one-fourth (1/4) vesting per year upon achievement of said objectives established by the Compensation Committee of the Issuer, subject to the Reporting Person's continued service through each vesting date. If performance objectives are not set by the Compensation Committee, the shares subject to the option will vest in equal annual installments over the following four years on the anniversary of the grant date, subject to the Reporting Person's continued service through each vesting date.